Free tool
FAERS Monitor: Orenitram
Last checked: Nov 20, 2026FDA FAERS (openFDA) last updated: Oct 28, 2026Methods & limitations
Reports naming NDA 203496 or its brand name (Orenitram, Treprostinil Diolamine). Reports on generic versions are filed under their own applications.
Reports
26,071
Serious
14,330
55% of reports
Hospitalization
9,778
Death reported
2,475
Any cause; not necessarily from the drug
Most reported reactions
MedDRA preferred terms.
- headache5,649
- diarrhoea4,908
- dyspnoea4,709
- nausea4,246
- fatigue2,600
- dizziness2,342
- vomiting2,190
- pain in extremity1,710
- flushing1,707
- hypotension1,516
- malaise1,509
- pain1,460
- death1,408
- dyspnoea exertional1,384
- cough1,359
Reports by year received
View as table
| Year | Reports |
|---|---|
| 2005 | 1 |
| 2006 | 3 |
| 2007 | 1 |
| 2008 | 2 |
| 2009 | 8 |
| 2010 | 13 |
| 2011 | 23 |
| 2012 | 41 |
| 2013 | 43 |
| 2014 | 386 |
| 2015 | 1,322 |
| 2016 | 1,826 |
| 2017 | 1,926 |
| 2018 | 2,198 |
| 2019 | 2,126 |
| 2020 | 2,001 |
| 2021 | 2,159 |
| 2022 | 2,381 |
| 2023 | 2,573 |
| 2024 | 2,241 |
| 2025 | 2,814 |
| 2026 | 1,983 |
Disproportionality screen
Proportional reporting ratio (PRR): how much more often each reaction appears in this drug's reports than in the other 21,028,088 FAERS reports. Flagged when PRR is at least 2, chi-squared at least 4 and there are 3 or more reports (Evans criteria). A screening statistic only.
| Reaction | Reports | PRR | 95% CI lower | Chi-squared |
|---|---|---|---|---|
| dyspnoea exertionalSignal | 1,384 | 30.7 | 29.2 | 38,394 |
| flushingSignal | 1,707 | 13.8 | 13.1 | 19,944 |
| headacheSignal | 5,649 | 7.3 | 7.2 | 31,513 |
| dyspnoeaSignal | 4,709 | 6.8 | 6.6 | 23,542 |
| diarrhoeaSignal | 4,908 | 6.2 | 6.0 | 21,780 |
| hypotensionSignal | 1,516 | 6.1 | 5.8 | 6,525 |
| pain in extremitySignal | 1,710 | 4.7 | 4.5 | 5,024 |
| nauseaSignal | 4,246 | 4.3 | 4.2 | 11,301 |
| coughSignal | 1,359 | 3.9 | 3.7 | 2,983 |
| dizzinessSignal | 2,342 | 3.8 | 3.7 | 4,926 |
| vomitingSignal | 2,190 | 3.8 | 3.6 | 4,536 |
| malaiseSignal | 1,509 | 2.8 | 2.6 | 1,751 |
| fatigueSignal | 2,600 | 2.7 | 2.6 | 2,878 |
| pain | 1,460 | 1.9 | 1.8 | 660 |
| death | 1,408 | 1.3 | 1.3 | 113 |
A high PRR for a reaction that is also the condition being treated (for example "disease progression" for a cancer drug) is expected and is not a safety signal.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.